Abbott Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

19.10.22	Abbott Laboratories Q3 Profit Decreases, but beats estimates (RTTNews)
19.10.22	Abbott Reports Third-Quarter 2022 Results and Raises Full-Year EPS Guidance (PR Newswire)
17.10.22	Abbott Recalls Certain Ready-to-Feed Liquid Products (RTTNews)
15.10.22	ROSEN, SKILLED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABT (PR Newswire)
12.10.22	Abbott and The Home Edit Redesign the Medicine Cabinet to Help People Prepare for the Upcoming Virus Season (PR Newswire)
08.10.22	ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT (PR Newswire)
06.10.22	New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life (PR Newswire)
28.09.22	ROSEN, A LONGSTANDING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT (PR Newswire)
28.09.22	Abbott Hosts Conference Call for Third-Quarter Earnings (PR Newswire)
17.09.22	ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT (PR Newswire)
17.09.22	Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies (PR Newswire)
15.09.22	Abbott Declares 395th Consecutive Quarterly Dividend (PR Newswire)
12.09.22	ABT INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT (PR Newswire)
08.09.22	Three-Year Data on World's Smallest Heart Device Show Benefits of Fixing Holes in Newborn Hearts Without Surgery (PR Newswire)
04.09.22	ROSEN, A LEADING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT (PR Newswire)
29.08.22	Abbott: Study Shows HeartMate 3 Pump Extends Life Expectancy Of Advanced Heart Failure Patients (RTTNews)
29.08.22	New Data Show Abbott's HeartMate 3™ Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients (PR Newswire)
23.08.22	Abbott Announces FDA Approval For Its Proclaim Plus Spinal Cord Stimulation System (RTTNews)
23.08.22	FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions (PR Newswire)
11.08.22	Abbott: Research Shows TBI Blood Test Helpful In Predicting Recovery From Traumatic Brain Injury (RTTNews)
11.08.22	New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions (PR Newswire)
04.08.22	Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals (PR Newswire)
26.07.22	Abbott Unveils NeuroSphere Virtual Clinic In Canada (RTTNews)
21.07.22	ABT Raises Earnings Forecast, BIIB Provides Rosy Revenue Outlook, ELV Q2 Revenue Up 15.6% (RTTNews)
20.07.22	Abbott Q2 Profit Tops Estimates; Raises 2022 Earnings Guidance (RTTNews)
20.07.22	Abbott Laboratories Q2 Profit Increases, beats estimates (RTTNews)
20.07.22	Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance (PR Newswire)
12.07.22	Abbott: FDA Grants Breakthrough Device Designation To Investigate DBS System In TRD (RTTNews)
12.07.22	Abbott Receives FDA's Breakthrough Device Designation to Explore Use of Deep Brain Stimulation to Manage Severe Depression (PR Newswire)
11.07.22	US To Import 4.9 Mln Cans Of Baby Formula From Australia (RTTNews)
01.07.22	US To Import 17 Mln Bottles Of Infant Formula From New Zealand, Ireland (RTTNews)
29.06.22	Abbott Hosts Conference Call for Second-Quarter Earnings (PR Newswire)
23.06.22	FDA Probes Death Of Infant Who Consumed Abbott Infant Formula (RTTNews)
10.06.22	Abbott Declares 394th Consecutive Quarterly Dividend (PR Newswire)
06.06.22	Abbott Restarts Baby Formula Production At Michigan Plant (RTTNews)
06.06.22	Abbott Says Data Show FreeStyle Libre 3 System Most Accurate 14-Day Continuous Glucose Monitor (RTTNews)
05.06.22	Late-Breaking Data Demonstrate Abbott's FreeStyle Libre® 3 System is Most Accurate 14-Day Continuous Glucose Monitor (PR Newswire)
03.06.22	Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System (PR Newswire)
31.05.22	Abbott Says FDA Oks FreeStyle Libre 3 System As Glucose Monitor For Diabetic Patients (RTTNews)
31.05.22	Abbott's FreeStyle Libre® 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor (PR Newswire)
25.05.22	US To Get About 2 Mln Infant Formula Cans From UK's Kendal Nutricare: FDA (RTTNews)
24.05.22	Abbott to Release EleCare® Amino Acid-based Formulas to Help Meet Critical Patient Need (PR Newswire)
19.05.22	Abbott Presents Data Reinforcing Impact Of Its Minimally Invasive Heart Devices (RTTNews)
19.05.22	New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies (PR Newswire)
17.05.22	Abbott Reaches Agreement With FDA To Restart Baby Formula Production Amid U.S. Shortage (RTTNews)
16.05.22	Abbott Enters into Consent Decree with U.S. Food and Drug Administration for its Sturgis, Mich., Plant; Agreement Creates Pathway to Reopen Facility (PR Newswire)
11.05.22	Abbott and Women as One Partner to Help More Underrepresented Physicians Lead Clinical Trials (PR Newswire)
04.05.22	Abbott Gets FDA Clearance For Alinity M STI Assay Test - Quick Facts (RTTNews)
04.05.22	Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise (PR Newswire)
29.04.22	Abbott to Release Metabolic Nutrition Formulas (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

19.11.24		Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten
19.11.24		Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus
19.11.24		Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein
19.11.24		Gewinne in New York: NASDAQ 100 legt zu
19.11.24		Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell
19.11.24		Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer
19.11.24		Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

19.11.24

Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten

19.11.24

Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus

19.11.24

Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein

19.11.24

Gewinne in New York: NASDAQ 100 legt zu

19.11.24

Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell

19.11.24

Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

19.11.24

Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

Nachrichten zu Abbott Laboratories

Aktien Top/Flop

Abbott Laboratories Peer Group Nachrichten

Meistgelesene Nachrichten